Dash Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for DASH PHARMS, and what generic and branded alternatives to DASH PHARMS drugs are available?
DASH PHARMS has eighteen approved drugs.
Drugs and US Patents for Dash Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dash Pharms | ACARBOSE | acarbose | TABLET;ORAL | 091053-003 | Jan 6, 2011 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Dash Pharms | ACARBOSE | acarbose | TABLET;ORAL | 091053-002 | Jan 6, 2011 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Dash Pharms | ETOPOSIDE | etoposide | INJECTABLE;INJECTION | 204927-001 | Oct 31, 2017 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Dash Pharms | ESCITALOPRAM OXALATE | escitalopram oxalate | TABLET;ORAL | 077550-003 | May 14, 2015 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Dash Pharms | ACARBOSE | acarbose | TABLET;ORAL | 091053-001 | Jan 6, 2011 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Dash Pharms | RISPERIDONE | risperidone | TABLET;ORAL | 076288-002 | Sep 15, 2008 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Dash Pharms | DISULFIRAM | disulfiram | TABLET;ORAL | 203916-002 | Mar 4, 2015 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.